carbidopa and levodopa tablet extended release
INDICATIONS AND USAGE Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
amneal pharmaceuticals ny llc
OVAL PURPLE G 391
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
CARBIDOPA AND LEVODOPA Extended-release Tablets USP, 50 mg/200 mg (carbidopa-levodopa) containing 50 mg of carbidopa and 200 mg of levodopa, are supplied as purple, oval, convex tablets, debossed with “G” left of bisect on one side and “391” on the other side with mottled appearance. They are supplied as follows: Bottles of 30: NDC 60219-2034-3 Bottles of 100: NDC 60219-2034-1 Bottles of 500: NDC 60219-2034-5
CARBIDOPA AND LEVODOPA Extended-release Tablets USP, 25 mg/100 mg (carbidopa-levodopa) containing 25 mg of carbidopa and 100 mg of levodopa, are supplied as purple, oval, convex tablets, debossed with “G” on one side and “392” on other side with mottled appearance. They are supplied as follows: Bottles of 30: NDC 60219-2033-3 Bottles of 100: NDC 60219-2033-1 Bottles of 500: NDC 60219-2033-5 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Store in a tightly closed container, protected from light and moisture. Dispense in a tightly-closed, light-resistant container.
More pills like OVAL G 391